Pharmaceutical Business review

AmerisourceBergen announces organizational changes

Michael DiCandilo, executive vice president and CFO of AmerisourceBergen, expands his responsibilities with the added position of COO for AmerisourceBergen Drug Corporation (ABDC) and continues to report directly to David Yost, president and CEO of AmerisourceBergen (ABC). The ABDC functions reporting to DiCandilo in his new role as ABDC’s COO are supply chain management, Operations, including the distribution network and financial operations, which previously reported to him. Yost continues to lead ABDC and continues to have the executives leading sales and marketing reporting to him.

Steven Collis, executive vice president of AmerisourceBergen and president, AmerisourceBergen Specialty Group (ABSG), expands his responsibilities to include supervision of PMSI, the company’s workers’ compensation business. Steve continues his responsibilities for helping shape the policy and strategy of ABC and for more closely integrating ABSG across AmerisourceBergen. He continues to report directly to Yost. Terrance Haas, executive vice president of AmerisourceBergen and chief integration officer, has left the company to pursue other interests.

Thomas Murphy, senior vice president and chief information officer, expands his responsibilities to include the leadership of business transformation, the company’s multi-year process improvement project, which includes design of an ERP (enterprise resource planning) system for ABDC and the corporation. Yost continues his executive leadership of business transformation. Murphy continues to report directly to DiCandilo.